CDKN2B Antikörper (Middle Region)
Kurzübersicht für CDKN2B Antikörper (Middle Region) (ABIN926911)
Target
Alle CDKN2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Rind (Kuh), Schwein, Hund
-
Aufreinigung
- Purified
-
Immunogen
- CDKN2 B antibody was raised in rabbit using the middle region of CDKN2 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CDKN2B Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CDKN2B antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Andere Bezeichnung
- CDKN2B
-
Hintergrund
- CDKN2B's gene lies adjacent to the tumor suppressor gene CDKN2A in a region that is frequently mutated and deleted in a wide variety of tumors. CDKN2B is a cyclin-dependent kinase inhibitor, which forms a complex with CDK4 or CDK6, and prevents the activation of the CDK kinases, thus the encoded protein functions as a cell growth regulator that controls cell cycle G1 progression. The expression of this gene was found to be dramatically induced by TGF beta, which suggested its role in the TGF beta induced growth inhibition. Synonyms: Polyclonal CDKN2B antibody, Anti-CDKN2B antibody, cyclin-dependent kinase inhibitor 2B, p15, inhibits CDK4 antibody.
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-